Form 8-K - Current report:
SEC Accession No. 0001104659-20-057485
Filing Date
2020-05-06
Accepted
2020-05-06 16:38:57
Documents
15
Period of Report
2020-05-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2018807d1_8k.htm   iXBRL 8-K 43368
2 EXHIBIT 2.1 tm2018807d1_ex2-1.htm EX-2.1 918731
3 EXHIBIT 99.1 tm2018807d1_ex99-1.htm EX-99.1 16326
7 GRAPHIC tm2018807d1_ex99-1img01.jpg GRAPHIC 5214
  Complete submission text file 0001104659-20-057485.txt   1348529

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ptct-20200505.xsd EX-101.SCH 3180
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptct-20200505_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptct-20200505_pre.xml EX-101.PRE 22706
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2018807d1_8k_htm.xml XML 3500
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 20853194
SIC: 2834 Pharmaceutical Preparations